Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Research and development spending
3Y CAGR
-6.5%/yr
vs +68.9%/yr prior
5Y CAGR
-2.8%/yr
Recent deceleration
Acceleration
-75.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $69.45M | -1.2% |
| 2024 | $70.27M | -3.8% |
| 2023 | $73.04M | -14.1% |
| 2022 | $85.08M | -18.3% |
| 2021 | $104.15M | +30.4% |
| 2020 | $79.89M | +81.4% |
| 2019 | $44.04M | +321.2% |
| 2018 | $10.46M | - |